Pilot Trial of a Smartphone Smoking Cessation Application Intervention for Cancer Patients (Quit2Heal Study)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 59
- 试验地点
- 2
- 主要终点
- 30-day point prevalence abstinence
研究概览
简要总结
The goal of this study is to determine whether the novel smartphone application designed specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than the current standard smoking cessation app.
详细描述
Cigarette smoking has harmful effects on cancer patients' treatment and prognosis, but there are systemic barriers to delivering smoking cessation interventions to cancer patients. One solution for addressing these barriers is to give patients immediate access to smoking cessation treatment via a smartphone application. The Quit2Heal smartphone app is engaging and tailored to the specific needs of cancer patients, and can be integrated into routine cancer care. The goal of this study is to determine whether Quit2Heal provides higher quit rates than the current standard smoking cessation app.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age 18 or older
- •diagnosed with cancer in the past 12 months
- •has smoked a cigarette (even a puff) in the past 30 days
- •interested in learning skills to quit smoking
- •willing to be randomly assigned to either smartphone application
- •resides in US
- •has at least daily access to their own smartphone
- •knows how to login and download a smartphone application from the Apple app store or Android Play app store
- •willing and able to read in English
- •not currently using cessation medications or enrolled in other smoking cessation programs, and
- •has never used the NCI's Quit Guide smartphone application.
- •willing and able to complete one follow-up survey
- •willing to provide email, phone, and mailing address.
排除标准
- •The exclusion criteria are opposite of the inclusion criteria listed above.
结局指标
主要结局
30-day point prevalence abstinence
时间窗: 2 months post randomization
No smoking in the past 30 days, as reported 2 months post treatment.
次要结局
未报告次要终点